Advertisement Pharmaceutical Business review - Page 1427 of 5281 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
July 10, 2026

Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar

Teva Pharmaceuticals International and Polpharma Biologics have signed a global licensing agreement for a proposed biosimilar to Ocrevus (ocrelizumab) to treat multiple sclerosis (MS).

Continue
Teva will take charge of regulatory submissions and, subject to approval, subsequent commercialisation in the specified territories. Credit: JHVEPhoto / Shutterstock.com.
July 10, 2026

Apertura and NIH institutes to test gene therapy for NPC1

Under the agreement, researchers plan to use Apertura’s TfR1 CapX adeno-associated virus capsid. Credit: H_Ko / Shutterstock.com.
July 8, 2026

FDA grants rare paediatric designation to Vanda’s CMT2S therapy

CMT2S is a rare, inherited neurological condition that progressively causes motor function loss and muscle weakness. Credit: SkazovD / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Sino and AstraZeneca sign licence agreement for TQC3721
  2. Evogene and Tel Aviv University launch drug discovery initiative
  3. Biocytogen and Whitehawk partner to develop ADCs
  4. Vertex signs agreement to acquire Crinetics for $10bn
  5. EC approves AbbVie’s Tepkinly combination for follicular lymphoma

PRESS RELEASES

SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
SCHOTT Pharma Expands Ready-to-Use Portfolio with Sterile 1.5ml Cartridge
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
Dr Imre Molnár Awarded With an Exceptional Scientific Honour – Tswett-Nernst European Award
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
HPLC 2025 in Bruges: Sharing Advanced Modelling Methods
Dr Imre Molnár Met Professor Ugur Sahin in Berlin, Laureate of the German National Prize, Together With His Wife Professor Özlem Türeci
Dr Imre Molnár Met Professor Ugur Sahin in Berlin, Laureate of the German National Prize, Together With His Wife Professor Özlem Türeci
Dr Imre Molnár Honoured With Tswett-Nernst European Award
Dr Imre Molnár Honoured With Tswett-Nernst European Award

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography